FARNUM RHONDA (SVP, Comm & Medical Affairs) sold 3.0% of their position (10K shares) of THERAVANCE BIOPHARMA, INC. on the open market
Open‑market sale worth $113.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 7/16/2025ACC: 0001415889-25-019869
Officer· SVP, Comm & Medical Affairs
Since Dec 2021
-10K
Net shares
Net seller
$113.9K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
10K disposed
Non-Derivative Transactions3
Ordinary Shares
Direct
Shares
−682.00
Price / share
$11.39
Trade value
$7.77K
% of position
0.2%
7/14/2025
336.92K→336.24K
Ordinary Shares
Direct
Shares
−5.32K
Price / share
$11.39
Trade value
$60.55K
% of position
1.6%
7/14/2025
336.24K→330.92K
Ordinary Shares
Direct
Shares
−4K
Price / share
$11.39
Trade value
$45.55K
% of position
1.2%
7/14/2025
330.92K→326.92K
Total
Net shares
−10K
Net value
-$113.87K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 7/14/2025 | S · Sale | −682.00 | $11.39 | $7.77K | 0.2% | 336.92K | 336.24K |
| Ordinary Shares Direct | 7/14/2025 | S · Sale | −5.32K | $11.39 | $60.55K | 1.6% | 336.24K | 330.92K |
| Ordinary Shares Direct | 7/14/2025 | S · Sale | −4K | $11.39 | $45.55K | 1.2% | 330.92K | 326.92K |
| Total | −10K | -$113.87K | ||||||
Derivative Transactions0
No derivative transactions reported